Understanding Regulation and Validation Processes for Biomarkers

Successfully Executing Biomarker Strategies

The successful execution of a biomarker strategy requires a flexible approach. Medpace offers an extensive menu of biomarkers that use state of the art techniques and provide results that enable patient stratification and improve prediction of drug efficacy and safety. Our central laboratory biomarker team is led by PhD level scientists who oversee the robust pipeline of new biomarker validations.

Medpace central lab and bioanalytical lab expertise in biomarker development and validation are enhanced by the experience and capabilities of our network of reference and strategic laboratory partners as a seamless service to our clients. We validate new biomarkers quickly in an industry-leading 10-12 weeks.

Our lab services include:

Anatomical Pathology
Companion Diagnostics
Cytogenetics
DNA/RNA Services
Genomics Analysis
FISH
Flow Cytometry
Fluorescence Microscopy
Functional and Receptor Assays
IHC Testing
Large and Small Molecule Expertise
Ligand Binding Assays
Mass Spectrometry: LC/MS/MS, GC/MS
Microbiology
Multiplex Platforms
PK/PD Testing
Proteomics
Virology

Global Labs – Fully Integrated for Efficiency

Because almost every clinical trial requires laboratory support, having wholly-owned entities with a broad range of capabilities and comprehensive test menus provides built-in efficiencies and collaboration. In concert with the Medpace CRO or working on standalone projects, experts from our central laboratories and bioanalytical laboratory can help plan and execute your testing needs.

Explore Our Biomarker Capabilities

Take a Virtual Tour